Informed consent for surgical treatment of hepatocellular carcinoma

Y. Sasaki, Terumasa Yamada, Hiroaki Ohigashi, Hidetoshi Eguchi, Osamu Ishikawa, Shingi Imaoka

Research output: Contribution to journalArticlepeer-review


Hepatocellular carcinoma (HCC) differs from other gastrointestinal cancers due to the following characteristics: 1) a high rate of recurrence, including multicentric recurrence; 2) the treatment modality or surgical method is often selected based on liver function: and 3) the indications for medical treatment versus surgery are not clearly defined and ther is no consensus on standard indications between surgeons and hepatologists. Therefore special informed consent must be obtained from HCC patients for surgery in addition to the standard written informed consent form. Moreover, because liver surgery carries the risk of massive intraoperative hemorrhage or postoperative liver failure, sufficient time must be spent explaining the associated risks to patients before obtaining informed consent.

Original languageEnglish
Pages (from-to)19-22
Number of pages4
JournalNippon Geka Gakkai zasshi
Issue number1
Publication statusPublished - Jan 2007
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Medicine(all)


Dive into the research topics of 'Informed consent for surgical treatment of hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this